Irving, J., Matheson, E., Minto, L., Blair, H., Case, M., Halsey, C., . . . Eckert, C. (2014). Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood.
Chicago Style CitationIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Cita MLAIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Atenció: Aquestes cites poden no estar 100% correctes.